Financials

News Discussions Technicals Seasonals

4882 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Perseus Proteomics, Inc. is a holding company that develops antibody-based therapeutics and diagnostics. It offers antibodies, which include nuclear receptors and epigenetics and sells antibodies against proteins and transcription factors involved in vascular inflammation. The company was founded by Akiyuki Furuya on February 1, 2001 and is headquartered in Tokyo, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

4882 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company